Schedule 13G ownership disclosure

Vor BioPharma Inc

Common Stock, $0.0001 par value per share · CUSIP: 929033207

Event date: 2025-09-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 760,699.00 · Class: 9.9%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 760,699.00 · Class: 9.9%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 760,699.00 · Class: 9.9%

  • VHCP Management III, LLC

    Shares: 760,699.00 · Class: 9.9%

  • VHCP Management EG, LLC

    Shares: 760,699.00 · Class: 9.9%

  • Nimish Shah

    Shares: 760,699.00 · Class: 9.9%

  • Bong Y. Koh

    Shares: 760,699.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001738048-25-000003
Form type
SCHEDULE 13G
Filer
Venrock Healthcare Capital Partners III, L.P.
CIK
CIK 1738048
Filed
Sep 25, 2025
Reporting period
Sep 18, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub